1. Home
  2. NWGL vs RLMD Comparison

NWGL vs RLMD Comparison

Compare NWGL & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • RLMD
  • Stock Information
  • Founded
  • NWGL 2008
  • RLMD 2004
  • Country
  • NWGL Macau
  • RLMD United States
  • Employees
  • NWGL N/A
  • RLMD N/A
  • Industry
  • NWGL
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • RLMD Health Care
  • Exchange
  • NWGL Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • NWGL 26.2M
  • RLMD 22.0M
  • IPO Year
  • NWGL 2023
  • RLMD N/A
  • Fundamental
  • Price
  • NWGL $1.11
  • RLMD $0.67
  • Analyst Decision
  • NWGL
  • RLMD Buy
  • Analyst Count
  • NWGL 0
  • RLMD 3
  • Target Price
  • NWGL N/A
  • RLMD $5.00
  • AVG Volume (30 Days)
  • NWGL 922.8K
  • RLMD 478.7K
  • Earning Date
  • NWGL 07-07-2025
  • RLMD 08-06-2025
  • Dividend Yield
  • NWGL N/A
  • RLMD N/A
  • EPS Growth
  • NWGL N/A
  • RLMD N/A
  • EPS
  • NWGL N/A
  • RLMD N/A
  • Revenue
  • NWGL $21,539,347.00
  • RLMD N/A
  • Revenue This Year
  • NWGL N/A
  • RLMD N/A
  • Revenue Next Year
  • NWGL N/A
  • RLMD N/A
  • P/E Ratio
  • NWGL N/A
  • RLMD N/A
  • Revenue Growth
  • NWGL N/A
  • RLMD N/A
  • 52 Week Low
  • NWGL $0.95
  • RLMD $0.24
  • 52 Week High
  • NWGL $6.61
  • RLMD $4.47
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 45.23
  • RLMD 52.84
  • Support Level
  • NWGL $1.32
  • RLMD $0.67
  • Resistance Level
  • NWGL $6.61
  • RLMD $0.72
  • Average True Range (ATR)
  • NWGL 0.61
  • RLMD 0.08
  • MACD
  • NWGL -0.10
  • RLMD -0.03
  • Stochastic Oscillator
  • NWGL 2.83
  • RLMD 40.29

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: